Search

Search Constraints

You searched for: Author/Creator Raffeld, Mark

Search Results

1. A novel approach for characterization of KSHV‐associated multicentric Castleman disease from effusions. (20th October 2022)

2. Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study. Issue 1 (January 2016)

4. Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in ATG9A. Issue 2 (1st February 2023)

5. Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial. Issue 8 (August 2020)

6. Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET. Issue 4 (21st February 2021)

7. CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development. (1st January 2022)

9. Clinicopathologic and Molecular Characterization of Epstein-Barr Virus–positive Plasmacytoma. (1st October 2022)

10. Clinicopathologic Features of Peripheral T-Cell Lymphoma in Sub-Saharan Africa. Issue 1 (2nd February 2021)